Southard leaves Elscint's U.S. unit
Donald Southard has left his position as vice president of salesand marketing at Elscint's U.S. subsidiary in Hackensack, NJ,for a position at cardiac monitoring firm Datascope. Southard'sdeparture was amicable, according to Dr. Thomas Spackman,
Donald Southard has left his position as vice president of salesand marketing at Elscint's U.S. subsidiary in Hackensack, NJ,for a position at cardiac monitoring firm Datascope. Southard'sdeparture was amicable, according to Dr. Thomas Spackman, presidentof the subsidiary.
"Don was terrific," Spackman said. "He broughtimagination, direction, enthusiasm, and fun to Elscint."
Southard joined Elscint in 1994 after serving as presidentand CEO of independent service provider Serviscope. He has alsoworked for OEMs Philips and Toshiba. Spackman has taken over Southard'sresponsibilities temporarily, while Elscint undergoes a reviewof its corporate organization that may result in changes to thesubsidiary's executive lineup, Spackman said.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
